Home / Compliance actions / 518204

FDA Warning Letter — Bloomingdale Wine & Spirits

Case 518204 — FEI 3013272257

The FDA took a Warning Letter action against Bloomingdale Wine & Spirits on Feb 23, 2017 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Bloomingdale Wine & Spirits
Date
Feb 23, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.